Process
1. Comprehensive Initial Consultation: Begin your journey with a thorough 30-45 minute session, whether in-person or virtual. During this consultation, we delve into your health history, recent lab results, dietary habits, and personal goals to devise a customized plan tailored to your needs.

2. Monthly Check-Ins: Monitor your progress and address any concerns with our 30-minute monthly sessions. These check-ins offer valuable opportunities to track your progress and refine your strategy for optimal results.

Pricing
• Initial Consultation: $200 (Includes first injection following review of lab results).
• Weekly Cost: Varied, ranging from $90 to $140, depending on prescribed medication (Semiglutide or Tirzepitide), determined during your consultation.

Additional Benefits
• Exclusive Discounts: Receive discounts on IV treatments, Vitamin Injections, and Biostimulator treatments throughout your weight loss journey.

Semiglutide/Trizepitide Treatment Overview
Semaglutide operates by mimicking the Glucagon-Like-Peptide (GLP) 1 hormone, naturally released in the gut following food consumption. At elevated doses, GLP-1 engages with specific brain regions responsible for appetite suppression and inducing feelings of fullness.

Tirzepatide functions as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and the glucagon-like peptide-1 (GLP-1) receptors. By stimulating these receptors, tirzepatide enhances insulin secretion in response to elevated blood glucose levels, suppresses glucagon secretion, slows gastric emptying, and promotes satiety. This multifaceted approach helps regulate blood sugar levels and reduces appetite, contributing to improved glycemic control and weight management.

When integrated into a comprehensive regimen of diet and exercise, Semaglutide or Trizepitide demonstrates the potential for substantial weight reduction among individuals grappling with obesity or overweight conditions.

According to FDA guidelines, the administration of Semaglutide or Trizepitide for weight loss is suggested under the following circumstances:

• Individuals with a body mass index (BMI) equal to or exceeding 27kg/m2, in conjunction with at least one weight-related ailment, such as hypertension, type 2 diabetes, or hypercholesterolemia.

• Individuals with a BMI of 30kg/m2 or higher.

Potential Side Effects or Complications
The side effects associated with Semaglutide or Trizepitide are generally mild, particularly when contrasted with the complications linked to overweight and obesity.

While undergoing Semaglutide or Trizepitide treatment, individuals may encounter the following:

• Gastrointestinal symptoms: Nausea/vomiting, abdominal pain, diarrhea/constipation, dyspepsia, abdominal distension, eructation, flatulence, gastroenteritis, GERD (gastroesophageal reflux disease), gastritis, increased lipase, increased amylase.

• Neurological manifestations: Headache, dizziness.

• Cardiac implications: Increased heart rate, hypotension.

• Endocrine effects: Fatigue, hypoglycemia (in diabetic patients), alopecia.

• Ophthalmic concerns: Retinal disorders (in diabetic patients).

• Dermatological reactions: Redness or pain at the injection site